Australia markets open in 6 hours 9 minutes

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.07-0.30 (-4.71%)
As of 01:50PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts8888
Avg. Estimate-0.47-0.43-2.17-1.05
Low estimate-0.55-0.56-2.4-2.37
High estimate-0.3-0.02-1.540.1
Year ago EPS0.72-0.52-0.72-2.17
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts8888
Avg. Estimate7M11.52M21.23M143.95M
Low estimate1.22M1.22M5.14M20M
High estimate29M65.1M96.8M322.5M
Year ago sales126.72M7.22M144.93M21.23M
Sales growth (year/est)-94.50%59.50%-85.40%578.00%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.46-0.44-0.52-0.6
Actual EPS0.72-0.52-0.61-0.7
Difference1.18-0.08-0.09-0.1
Surprise %256.50%-18.20%-17.30%-16.70%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.47-0.43-2.17-1.05
7 days ago-0.47-0.43-2.17-1.05
30 days ago-0.47-0.43-2.17-1.05
60 days ago-0.55-0.57-2.32-1.07
90 days ago-0.55-0.57-2.33-1.07
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMCRBIndustrySector(s)S&P 500
Current qtr.-165.30%N/AN/AN/A
Next qtr.17.30%N/AN/AN/A
Current year-201.40%N/AN/AN/A
Next year51.60%N/AN/AN/A
Next 5 years (per annum)-134.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A